8 news items
Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
RYTM
6 May 24
biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. Rhythm's lead asset
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
RYTM
29 Apr 24
Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
RYTM
24 Apr 24
. About Rhythm Pharmaceuticals Rhythm is a commercial-stage biopharmaceutical company committed to transforming the lives
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
ATNM
AZN
BMY
18 Apr 24
results or events. Past performance does not guarantee future results.InvestorBrandMedia.com does not commit to updating forward-looking statements
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
RYTM
16 Apr 24
. About Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients
0uz6bcp69 emu4hw
RYTM
11 Mar 24
Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients
21rf44cprldk6nww4urah25siutlluzvq
RYTM
6 Mar 24
following the presentation. About Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed
j32dh27uafsgvy9xoixhd2umvizwk 2y81fuwlbxo8i5ob
RYTM
22 Feb 24
. About Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed to transforming the lives
- Prev
- 1
- Next